Psychometric properties of the Federal Unit Scale for general psychopathology screening without iatrogenic effects.

Tyler M Moore¹, Kathryn Walker², Franz Hell³, Grayson Rosenblad⁴, Andrew Cutler³, Adam R Teed³, Maria Coté J Auil⁵, Rex Jung⁶, Shobi S Ahmed³

¹Sama Therapeutics, Cambridge, MA, 02141, USA; Department of Psychiatry, Brain Behavior Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA; Lifespan Brain Institute (LiBI), Children's Hospital of Philadelphia and Penn Medicine, Philadelphia, PA, 19104, USA. Electronic address: tyler@sama.ac.

²Revitalist Lifestyle and Wellness, Ltd, Canada.

³Sama Therapeutics, Cambridge, MA, 02141, USA.

⁴The Webb School, Knoxville, TN, 37923, USA.

⁵Evidation Health, San Mateo, CA, 94401, USA.

⁶Sama Therapeutics, Cambridge, MA, 02141, USA; Brain and Behavioral Associates, Albuquerque, NM, 87106, USA.

PubMed DOI

Abstract

Mental health assessment tools play a crucial role in clinical practice, yet many existing scales risk exacerbating the conditions they aim to measure. This study introduces the Federal Unit Scale (FUS), a novel 5-item scale designed to assess a broad range of affect and traits capturing distress tolerance while minimizing potentially triggering language. The FUS was developed with a focus on comb…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.